Communications
oral (42 documents )
3D Cultures of Parkinson's Disease‐Specific Dopaminergic Neurons for High Content Phenotyping and Drug TestingJens Christian Schwambornabstract : oralTopic 8: from single cell to 3D models (2)sciencesconf.org:hope2020:286551
|
3D structure determination of amyloid fibrils using solid-state NMR spectroscopy.Antoine Loquetabstract : oralTopic 3: What do we learn from a-synuclein inclusions?sciencesconf.org:hope2020:275297
|
A brain-spine interface alleviating gait deficits in a primate model of parkinson's diseaseJocelyne Bloch-Pascheabstract : oralTopic 7: Preclinical and Translational developmentssciencesconf.org:hope2020:286544
|
Acidic nanoparticles prevent neurodegeneration in LB-induced Parkinson's disease mouse modelMarie-Laure AROTCARENA, Federico Soria, Geoffrey Prévot, Anthony Cunha, Evelyne Doudnikoff, Erwan Bezard, Benjamin Dehayabstract : oralTopic 7: Preclinical and Translational developmentssciencesconf.org:hope2020:299926
|
Alpha-synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulbNolwen Rey, Luc Bousset, Sonia George, Zachary Madaj, Lindsay Meyerdirk, Emilie Schulz, Jennifer A. Steiner, Ronald Melki, Patrik Brundinabstract : oralTopic 3: What do we learn from a-synuclein inclusions?sciencesconf.org:hope2020:302629
|
|
An update on the Genetics of Parkinson's diseaseVincenzo Bonifatiabstract : oralTopic 1: Genome wide Analyses - Genetics and Transcriptomicssciencesconf.org:hope2020:269083
|
|
|
Can we use brain connectivity to improve individual patient DBS outcomes?Brian Lauabstract : oralTopic 2: Recent advances in Imagingsciencesconf.org:hope2020:275292
|
Cellular Brain Repair for Parkinson's Disease: Is the Answer in the (Biomaterial) Matrix?Eilis Dowdabstract : oralTopic 8: From single cell to 3D models (1)sciencesconf.org:hope2020:286545
|
Cellular mechanisms underlying LRRK2-related Parkinson´s diseaseSabine Hilfikerabstract : oralTopic 6: Molecular modelling using other Parkinson's disease genessciencesconf.org:hope2020:286539
|
|
Characterising the role of alpha synuclein in Ferroptosis in the context go Parkinson's diseaseLaura Mahoney Sanchez, Hind Bouchaoui, Aurélie Jonneaux, Scott Ayton, James Duce, David Devos, Jean-Christophe Devedjianabstract : oralTopic 4: Localisation and regulation of a-synucleinsciencesconf.org:hope2020:303371
|
Conférence plénière ouverte au public : La chirurgie dans la maladie de Parkinson, état de l'art et perspectivesStéphane Palfiabstract : oralTopic 5: Patients & associationssciencesconf.org:hope2020:286536
|
|
Deciphering the cellular and molecular response of human dopaminergic neurons to mitochondrial stressJana Heneine, Claire Colace-Sauty, Justine Guegan, Corinne Pardanaud-Glavieux, Ben Galet, Emeline Hamon, Olga Corti, Philippe Ravassard, Hélène Chevalabstract : oralTopic 1: Genetics and Epigenetics determinantssciencesconf.org:hope2020:308907
|
Evaluation of dopaminergic neuronal loss and synaptic changes in an α-synuclein overexpressing model of PDPauline Roost, Francesco Gubinelli, Pauline Gipchtein, Mylène Gaudin, Martine Guillermier, Noémie Cresto, Leopold Eymin, Charlène Josephine, Marie-Claude Gaillard, Alexis Bemelmans, Yann Bramoullé, Emmanuel Brouillet, Philippe Hantraye, Nadja Van Campabstract : oralTopic 2: Recent advances in Imagingsciencesconf.org:hope2020:303332
|
|
From bench to bedside in a peculiar synucleopathy: the multiple system atrophyWassilios Meissnerabstract : oralTopic 7: Preclinical and Translational developmentssciencesconf.org:hope2020:286543
|
GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association studyAgustin Ruizabstract : oralTopic 1: Genome wide Analyses - Genetics and Transcriptomicssciencesconf.org:hope2020:286508
|
GCI-induced neurodegeneration and synucleinopathy in non-human primatesMargaux Teil, Sandra Dovero, Mathieu Bourdenx, Marie-Laure AROTCARENA, Sandrine Camus, Gregory Porras, Marie-Laure Thiolat, Niels Kruse, Brit Mollenhauer, Inés Trigo Damas, Cristina Estrada, Nuria Garcia-Carrillo, María Trinidad Herrero Ezquerro, Pascal Derkinderen, Miquel Vila, José A. Obeso, Benjamin Dehay, Erwan Bezardabstract : oralTopic 3: What do we learn from a-synuclein inclusions?sciencesconf.org:hope2020:301074
|
Identification of targets and markers of Parkinson's disease-associated neuroinflammationCansu YILDIRIM, Luc Bousset, Lina Gomez, Alexis Fenyi, Ronald Melki, Stéphane Hunotabstract : oralTopic 4: Localisation and regulation of a-synucleinsciencesconf.org:hope2020:303185
|
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's diseasePierre-Olivier Fernagutabstract : oralTopic 7: Preclinical and Translational developmentssciencesconf.org:hope2020:286541
|
iPSC neuronal models of Parkinson's: from pathological mechanisms to target discoveryRichard Wade-Martinsabstract : oralTopic 8: From single cell to 3D modelssciencesconf.org:hope2020:286546
|
|
LRRK2 interacts with a subset of endosomal vesicular SNAREs: potential role in the physiopathology of Parkinson DiseaseFrancesca Filippini, Sebastien Nola, Jean-Marc Taymans, Marie-Christine Chattier-Harlin, Thierry Galliabstract : oralTopic 6: Molecular modelling using other Parkinson's disease genessciencesconf.org:hope2020:303397
|
Mitochondrial dysfunctions caused by neuron-related RNA binding protein misexpressionStylianos Ravanidis, Marianna Naki, Fedon-Giasin Kattan, Epaminondas Doxakisabstract : oralTopic 1: Genetics and Epigenetics determinantssciencesconf.org:hope2020:302172
|
|
|
Neuronal Parkinson inclusions are different than expectedHenning Stahlbergabstract : oralTopic 3: What do we learn from a-synuclein inclusions?sciencesconf.org:hope2020:275299
|
Neuropathology of Parkinson' s disease and dementia of Lewy Bodies.Charles Duyckaertsabstract : oralTopic 3: What do we learn from a-synuclein inclusions?sciencesconf.org:hope2020:275296
|
New insights into the complex role of mitochondria in Parkinson's diseaseAnne Grünewaldabstract : oralTopic 8: from single cell to 3D models (2)sciencesconf.org:hope2020:286548
|
Pathophysiology of dyskinesia and behavioral disorders in non-human primates: Insights from multimodal imagingVéronique Sgambatoabstract : oralTopic 2: Recent advances in Imagingsciencesconf.org:hope2020:286534
|
Posttranslational modifications: modulators of alpha-synuclein biology and pathobiologyTiago Fleming Outeiroabstract : oralTopic 4: Localisation and regulation of a-synucleinsciencesconf.org:hope2020:275305
|
Potential of dopamine neurons derived from human induced pluripotent stem cells reprogrammed by mRNA for Parkinson's diseaseSébastien BROT, Marie Laure Bonnet, Maureen Francheteau, Laure Belnoue, Afsaneh Gaillardabstract : oralTopic 7: Preclinical and Translational developmentssciencesconf.org:hope2020:302861
|
|
Specific vulnerability of neuronal populations & Transfer of alpha-synuclein in reconstructed neural networksJosquin Courte, Luc Bousset, Ysander Von Boxberg, Catherine VILLARD, Ronald Melki, Jean-Michel Peyrinabstract : oralTopic 8: From single cell to 3D modelssciencesconf.org:hope2020:303369
|
The role of Lipid Droplets in Parkinson's DiseaseBertrand Mollereauabstract : oralTopic 6: Molecular modelling using other Parkinson's disease genessciencesconf.org:hope2020:275358
|
Transcriptional regulation of alpha-synuclein by the TRIM17-TRIM41-ZSCAN21 pathwaySolange Desagherabstract : oralTopic 4: Localisation and regulation of a-synucleinsciencesconf.org:hope2020:275308
|
Transcriptomic signatures of brain regional vulnerability to Parkinson's diseaseArlin Keoabstract : oralTopic 1: Genome wide Analyses - Genetics and Transcriptomicssciencesconf.org:hope2020:309154
|
Triallelic stem cell model of Parkinson's disease reveals epistatic interaction between PRKN and GBAZoé Hanss, Ibrahim Boussaad, François Massart, Gérald Cruciani, Simone B. Larsen, Julia I. Forster, Gizem Önal, Serap Dokmeci, Stefano Goldwurm, Rejko Krügerabstract : oralTopic 6: Molecular modelling using other Parkinson's disease genessciencesconf.org:hope2020:303167
|
poster (15 documents )
15-Lipoxygenase: a promising therapeutic target, to block Ferroptosis cell death in Parkinson's diseaseHind Bouchaouiabstract : postersciencesconf.org:hope2020:303653
|
Alpha-synuclein and LRRK2's cooperation in Parkinson's Disease : a focus on autophagyFanny Lebourg, Camille Gardier, Marie-Claude Gaillard, Noëlle Dufour, Alexis Bemelmans, Emmanuel Brouillet, Géraldine Liotabstract : postersciencesconf.org:hope2020:301785
|
Alpha-synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulbNolwen Rey, Luc Bousset, Sonia George, Zachary Madaj, Lindsay Meyerdirk, Emilie Schulz, Jennifer A. Steiner, Ronald Melki, Patrik Brundinabstract : postersciencesconf.org:hope2020:302630
|
Cognitive ability characterization of rat model with mutated alpha-synuclein overexpressionCharlotte Laloux, Cédrick Lachaud, Kelly Timmerman, Clémence Leboulanger, Florent Auger, Erwan Bezard, Régis Bordet, David Devosabstract : postersciencesconf.org:hope2020:302563
|
Conception d'aptamères dirigés contre la protéine α-SynucléineAlix Bouvier-Müller, Luc Bousset, Ronald Melki, Frédéric Ducongéabstract : postersciencesconf.org:hope2020:302526
|
High Content Screening of synucleinopathy in primary cortical neuronsFlorent Laferriere, Francesca De Giorgi, Federica Zinghirino, Benjamin Dehay, Erwan Bézard, François Ichasabstract : postersciencesconf.org:hope2020:303278
|
LRRK2 and deficits of membrane trafficking in Parkinson DiseaseAntoine Marchand, Alessia Sarchione, Francesca Filippini, Sebastien Nola, Thierry Galli, Marie-Christine Chartier-Harlin, Jean-Marc Taymansabstract : posterTopic 6: Molecular modelling using other Parkinson's disease genessciencesconf.org:hope2020:303651
|
Modulation of an ageing pathway protects neurons and facilitates regeneration in models of Parkinson's diseaseRacha Al Tannir, Yolanda Colino-Sanguino, Ivan Gallotta, Sean Coakley, Mathilde Faideau, Sandro Montefusco, Annamaria Carissimo, Massimo Hilliard, Diego Medina, Elia Di Schiavi, Mickael Decressacabstract : postersciencesconf.org:hope2020:303430
|
Molecular exploration of the effect of the PARK7 PD-associated mutation c.192G>CZoé Hanss, Ibrahim Boussaad, Coline Leghay, Caroline Obermaier, Adriana Figueroa-Garcia, Amélie Vizeneux, Pierre Semaille, François Massart, Marie-Christine Chartier-Harlin, Rejko Krügerabstract : postersciencesconf.org:hope2020:308962
|
Molecular tweezer protects against alpha synuclein-induced neuronal toxicityEmilie Faggiani, Francesca De Giorgi, François Ichas, Benjamin Dehay, Erwan Bezardabstract : postersciencesconf.org:hope2020:301014
|
Role of glial reactivity in α-synuclein-induced neurodegeneration in the Drosophila modelAmélie Hu, Baya Cherif-Zahar, Serge Birmanabstract : postersciencesconf.org:hope2020:308935
|
Sleep/wake activity in the Lewy bodies models of Parkinson's diseaseMarine Persillet, Fanny Decoeur, Tao Zhu, Ling Zhang, Xianglei Li, Changsong Dou, Xiuping Sun, Yu Zhang, Xuan Yu, Li Zhou, Gao Ran, Ludivine S. Breger, Sandra Dovero, Chuan Qin, Gregory Porras, Christian Gross, Benjamin Dehay, Agnès Nadjar, Erwan Bezardabstract : postersciencesconf.org:hope2020:302087
|
The PINK1 kinase-driven ubiquitin ligase Parkin promotes mitochondrial protein import through the presequence pathway in living cellsEmeline Hamon, Maxime Jacoupy, Alban Ordureau, Zoi Erpapazoglou, J. W. Harper, Denis Guedin, Clément Gautier, Olga Cortiabstract : postersciencesconf.org:hope2020:303364
|
Triallelic stem cell model of Parkinson's disease reveals epistatic interaction between PRKN and GBAZoé Hanss, Ibrahim Boussaad, François Massart, Gérald Cruciani, Simone Larsen, Julia Forster, Gizem Önal, Serap Dokmeci, Stefano Goldwurm, Rejko Krügerabstract : postersciencesconf.org:hope2020:308785
|
α-synuclein and deficits of membrane trafficking in Parkinson's DiseaseAlessia Sarchione, Antoine Marchand, Francesca Filippini, Sebastien Nola, Thierry Galli, Jean-Marc Taymans, Marie-Christine Chartier-Harlinabstract : posterTopic 4: Localisation and regulation of a-synucleinsciencesconf.org:hope2020:303654
|
|